HOME >> MEDICINE >> NEWS
Gastric bypass surgery resolves or improves diabetes in most patients, reports Pittsburgh study

Mean body mass index was 50.

"Prior to surgery, the disease severity for these patients was quite significant overall," said Dr. Schauer, "with 65 percent of them requiring oral agents and 27 percent of them requiring insulin as well."

Post surgery, patients had a mean excess weight loss of 60 percent and a body mass index of 34 after 20 months. Fasting plasma glucose and glycoslated hemoglobin concentrations returned to normal levels in 83 percent of patients, while 17 percent of patients markedly improved. Following surgery, 80 percent of patients had a significant reduction in the use of oral anti-diabetic agents and 79 percent had a reduction in their use of insulin.

"The impressive effect of bypass surgery on morbidly obese patients with type 2 diabetes raises an argument for lowering the threshold for surgical intervention to moderate or mild obesity," Dr. Schauer said. "Further investigation demonstrating risk versus benefit for patients with moderate obesity is warranted."

The LGBP procedure involves constructing a small stomach pouch of approximately 15 millimeters (about the size of a plastic medicine cup), and bypassing a small segment of intestines by constructing a Y-shaped limb of small bowel. Patients lose weight because there is a decrease in caloric intake resulting from the reduced reservoir capacity of the small stomach pouch.

Type 2 diabetes is the most common form of diabetes, in which the body is unable to properly use the insulin that it produces. About 80 percent of people with type 2 diabetes are overweight.


'"/>

Contact: Frank Raczkiewicz
RaczkiewiczFA@upmc.edu
412-647-3555
University of Pittsburgh Medical Center
2-Oct-2003


Page: 1 2

Related medicine news :

1. Gastric bypass works for GERD and obesity in patients with prior surgery, says Pitt study
2. Gastric bypass and stomach-stapling patients should recognize risk of nerve injury post-surgery
3. Gastric bypass surgery is riskiest for those who need it most
4. Gastric bypass surgery riskiest for those who need it most
5. Gastric bypass surgery for obesity may ease symptoms of gastroesophageal reflux disease
6. Drug And Radiation Treatment May Shrink Pancreatic And Gastric Tumors
7. Health care report cards may increase racial/ethnic disparities in bypass operations
8. Gender a factor in who gets bypass surgery
9. Angioplasty, robotically assisted keyhole bypass combo appears effective
10. Combining liver transplantation and coronary artery bypass grafting can be safe and effective
11. Laparoscopic gastric bypass surgery effectively improves obesity-related health problems

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... PureLife Dental ... endorsed amalgam separator supplier for CDA members. As part of the amalgam separator endorsement, ... of $99, saving more than $400 off the retail value. This partnership between PureLife ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... financial planning, and related services to families and business owners in and around ... drive to benefit senior citizens in the area. , Meals on Wheels of ...
(Date:6/23/2017)... TX (PRWEB) , ... June 23, 2017 , ... ... and business owners in the Houston area with access to asset protection and ... a regional charity event aimed at improving the lives of children with cancer ...
(Date:6/22/2017)... ... June 22, 2017 , ... Groove Ring is excited ... about their high performance silicon wedding bands and all-purpose rings. Whether you’re an athlete, ... silicone rings designed just for you. , From the rock face to the auto ...
(Date:6/22/2017)... MN (PRWEB) , ... June 22, 2017 , ... ... the world, announced today that it has received certification for ANSI/ASIS PSC.1-2012. The ... often occurs in environments where the rule of law has been degraded. The ...
Breaking Medicine News(10 mins):
(Date:6/11/2017)... -- Eli Lilly and Company (NYSE: LLY ) announced ... galcanezumab, an investigational treatment for the prevention of episodic ... secondary endpoints for galcanezumab compared to placebo at both ... and REGAIN) will be presented today at the American ... Boston . "The detailed Phase ...
(Date:6/9/2017)... , June 9, 2017 More than 400 ... effort to help spread lessons learned from clinical research ... Diabetes Federation (IDF) and Eli Lilly and Company (NYSE: ... second phase of the Bringing Research in Diabetes to ... commitment to helping people with diabetes effectively manage their ...
(Date:6/8/2017)... , June 8, 2017  StatLab Medical ... developer and manufacturer of diagnostic supplies for ... that Cressey & Company LP ("Cressey & ... completed a growth-focused investment in the Company. ... ownership position from selling shareholder, Prairie Capital, ...
Breaking Medicine Technology:
Cached News: